That's a horror story. The world needs several new classes of antibiotics, and the sooner the better.

The shorts and bashers should be very proud that they have killed untold numbers of people, by reaping their selfish short-selling profits while slowing the rate of progress of Brilacidin trials. Good work, monsters. Make sure you tell your families and friends about your great accomplishment -- assuming that they haven't succumbed to some infection that would have been treatable with Brilacidin.